KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Restructuring Costs (2019)

Twist Bioscience (TWST) has disclosed Restructuring Costs for 1 consecutive years, with $22.5 million as the latest value for Q4 2019.

  • On a quarterly basis, Restructuring Costs changed N/A to $22.5 million in Q4 2019 year-over-year; TTM through Sep 2020 was $22.5 million, a N/A change, with the full-year FY2020 number at $22.5 million, changed N/A from a year prior.
  • Restructuring Costs was $22.5 million for Q4 2019 at Twist Bioscience.
  • In the past five years, Restructuring Costs ranged from a high of $22.5 million in Q4 2019 to a low of $22.5 million in Q4 2019.